Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regorafenib in Advanced Urothelial Cancer
NCT02459119Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- May 2015
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of regorafenib in urothelial carcinoma (UC), sponsored by University of Alabama at Birmingham. Started May 2015; status: completed.
02
Drugs
regorafenib
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT02459119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02459119.